\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ surgery\\ followed\\ by\\ radiation\\ therapy\\.\ \(0\)\
\-\ \\â\\€\\¢\\ 4\\ cm\\ mass\\ in\\ right\\ cerebellar\\ hemisphere\\.\ \(1\)\
\-\ \\â\\€\\¢\\ isointense\\ to\\ slighly\\ hyperintense\\ on\\ t1\ \(0\)\
\-\ \\â\\€\\¢\\ very\\ low\\ signal\\ on\\ t2\\ images\ \(0\)\
\-\ \\â\\€\\¢\\ heterogeneous\\ enhancement\\ following\\ contrast\\.\ \(0\)\
\-\ cerebellar\\ metastatic\\ disease\\ from\\ colon\\ cancer\ \(0\)\
\-\ \\â\\€\\¢\\ cerebellar\\ hematoma\\ secondary\\ to\\ vascular\\ malformation\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ metastatic\\ adenocarcinoma\\ with\\ mucin\\ \\(colon\\ cancer\\)\ \(0\)\
\-\ \\â\\€\\¢\\ primary\\ glioma\\ \\(high\\ grade\\)\ \(0\)\
\-\ 50\\ \\ year\\ old\\ \\ woman\\ with\\ history\\ of\\ colon\\ cancer\\ with\\ known\\ metastatic\\ disease\\ to\\ the\\ liver\\.\\ \\ presents\\ to\\ local\\ doctor\\ with\\ headache\\ and\\ ataxia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.13479693347061403\ \(0\)\
\-\ cerebellar\\:\\ 0\\.1188909583562395\ \(0\)\
\-\ colon\\:\\ 0\\.10825590031684966\ \(0\)\
\-\ slighly\\:\\ 0\\.09479052068781181\ \(0\)\
\-\ cancer\\:\\ 0\\.09061823433434726\ \(0\)\
\-\ metastatic\\:\\ 0\\.06939062592309968\ \(0\)\
\-\ mucin\\:\\ 0\\.06567170132112138\ \(0\)\
\-\ doctor\\:\\ 0\\.05567669101333455\ \(0\)\
\-\ ataxia\\:\\ 0\\.04910777614964666\ \(0\)\
\-\ hemisphere\\:\\ 0\\.046770003282923814\ \(0\)\
\-\ isointense\\:\\ 0\\.04516556889381977\ \(0\)\
\-\ local\\:\\ 0\\.04220612145962091\ \(0\)\
\-\ glioma\\:\\ 0\\.04142659993232894\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.03969413381250795\ \(0\)\
\-\ hyperintense\\:\\ 0\\.03814688456885129\ \(0\)\
\-\ malformation\\:\\ 0\\.03664888873662774\ \(0\)\
\-\ grade\\:\\ 0\\.03499824508549431\ \(0\)\
\-\ 50\\:\\ 0\\.034956967920901125\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.03393587320652556\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.03378704469672049\ \(0\)\
\-\ very\\:\\ 0\\.03335253353179709\ \(0\)\
\-\ hematoma\\:\\ 0\\.03269856858518377\ \(0\)\
\-\ liver\\:\\ 0\\.03167980119174972\ \(0\)\
\-\ headache\\:\\ 0\\.03155898319963224\ \(0\)\
\-\ followed\\:\\ 0\\.03080511689654593\ \(0\)\
\-\ radiation\\:\\ 0\\.03015323924260577\ \(0\)\
\-\ vascular\\:\\ 0\\.03012691685939459\ \(0\)\
\-\ disease\\:\\ 0\\.03003736647775708\ \(0\)\
\-\ t1\\:\\ 0\\.02912360791638972\ \(0\)\
\-\ known\\:\\ 0\\.029075818112514192\ \(0\)\
\-\ primary\\:\\ 0\\.02721918562253437\ \(0\)\
\-\ lymphoma\\:\\ 0\\.02626020036977942\ \(0\)\
\-\ following\\:\\ 0\\.026078255450549984\ \(0\)\
\-\ t2\\:\\ 0\\.026006330846777982\ \(0\)\
\-\ secondary\\:\\ 0\\.025688494263535568\ \(0\)\
\-\ 4\\:\\ 0\\.025601848442785433\ \(0\)\
\-\ low\\:\\ 0\\.02555019411684301\ \(0\)\
\-\ high\\:\\ 0\\.02514565657071845\ \(0\)\
\-\ cm\\:\\ 0\\.024644689438892323\ \(0\)\
\-\ enhancement\\:\\ 0\\.02462891146368856\ \(0\)\
\-\ therapy\\:\\ 0\\.024566030067103367\ \(0\)\
\-\ signal\\:\\ 0\\.024226605701857837\ \(0\)\
\-\ surgery\\:\\ 0\\.022311817896347043\ \(0\)\
\-\ woman\\:\\ 0\\.0212247628762248\ \(0\)\
\-\ contrast\\:\\ 0\\.020567480503310812\ \(0\)\
\-\ presents\\:\\ 0\\.01877036876890243\ \(0\)\
\-\ to\\:\\ 0\\.01836852079324672\ \(0\)\
\-\ images\\:\\ 0\\.017626493461821012\ \(0\)\
\-\ on\\:\\ 0\\.01556754865301996\ \(0\)\
\-\ \\(\\:\\ 0\\.015534660779437862\ \(0\)\
\-\ \\)\\:\\ 0\\.015344896604587207\ \(0\)\
\-\ by\\:\\ 0\\.01529968713166532\ \(0\)\
\-\ from\\:\\ 0\\.013617588313486155\ \(0\)\
\-\ mass\\:\\ 0\\.012779150612339404\ \(0\)\
\-\ history\\:\\ 0\\.012690478900076166\ \(0\)\
\-\ year\\:\\ 0\\.010280701820138868\ \(0\)\
\-\ right\\:\\ 0\\.009694964614090503\ \(0\)\
\-\ old\\:\\ 0\\.009407898890991986\ \(0\)\
\-\ with\\:\\ 0\\.005032437681285581\ \(0\)\
\-\ in\\:\\ 0\\.004531153012260806\ \(0\)\
\-\ and\\:\\ 0\\.001935580706798048\ \(0\)\
\-\ \\.\\:\\ 0\\.001908577209534746\ \(0\)\
\-\ the\\:\\ 0\\.001486551448426084\ \(0\)\
\-\ of\\:\\ 0\\.0012527290408385853\ \(0\)\
